Cart
Article
Synthesis and Characterization of Platinum(IV) Anticancer Drugs with Functionalized Aromatic Carboxylate Ligands: Influence of the Ligands on Drug Efficacies and Uptake
Full Text HTML
Hi-Res PDFPurchase the full-text
- PDF/HTML,
figures/images,
references and tables,
(where available)
Section:Abstract
A series of trans-platinum(IV) complexes with functionalized aromatic carboxylate ligands, cis,cis,trans-Pt(NH3)2Cl2(CO2C6H4R)2 (R = H (3), p-vinyl (4), p-methoxy (5), p-iodo (6), p-cyano (7), or o-carboxyl (8)) was synthesized and characterized by spectroscopic methods. Crystal structures of 3, 4, 7, and 8 were obtained, which revealed that their structural conformations were influenced by intramolecular H-bonding interactions. The complexes were evaluated for cellular uptake and inhibition of cell proliferation against a panel of lung, colon, and breast carcinoma cell lines. The functionalization of the aromatic carboxylate ligand was found to have a profound influence on the uptake, and hence, efficacy, of this class of complex.
Citing Articles
Citation data is made available by participants in CrossRef's Cited-by Linking service. For a more comprehensive list of citations to this article, users are encouraged to perform a search in SciFinder.
This article has been cited by 9 ACS Journal articles (5 most recent appear below).
Characterization of New Potential Anticancer Drugs Designed To Overcome Glutathione Transferase Mediated Resistance
Katarina Johansson, Mika Ito, Carolien M. S. Schophuizen, Sherin Mathew Thengumtharayil, Vanina D. Heuser, Jie Zhang, Miyuki Shimoji, Marie Vahter, Wee Han Ang, Paul J. Dyson, Aya Shibata, Satoshi Shuto, Yoshihiro, Ito, Hiroshi Abe, and Ralf MorgensternMolecular Pharmaceutics2011 8 (5), 1698-1708Characterization of New Potential Anticancer Drugs Designed To Overcome Glutathione Transferase Mediated Resistance
Katarina Johansson, Mika Ito, Carolien M. S. Schophuizen, Sherin Mathew Thengumtharayil, Vanina D. Heuser, Jie Zhang, Miyuki Shimoji, Marie Vahter, Wee Han Ang, Paul J. Dyson, Aya Shibata, Satoshi Shuto, Yoshihiro, Ito, Hiroshi Abe, and Ralf MorgensternMolecular Pharmaceutics2011 8 (5), 1698-1708Resistance against anticancer drugs remains a serious obstacle in cancer treatment. Here we used novel strategies to target microsomal glutathione transferase 1 (MGST1) and glutathione transferase pi (GSTP) that are often overexpressed in tumors and ...
Synthesis, Characterization, and Cytotoxicity of Platinum(IV) Carbamate Complexes
Justin J. Wilson and Stephen J. LippardInorganic Chemistry2011 50 (7), 3103-3115Synthesis, Characterization, and Cytotoxicity of Platinum(IV) Carbamate Complexes
Justin J. Wilson and Stephen J. LippardInorganic Chemistry2011 50 (7), 3103-3115The synthesis, characterization, and cytotoxicity of eight new platinum(IV) complexes having the general formula cis,cis,trans-[Pt(NH3)2Cl2(O2CNHR)2] are reported, where R = tert-butyl (4), cyclopentyl (5), cyclohexyl (6), phenyl (7), p-tolyl (8), p-...
Polymer−Cisplatin Conjugate Nanoparticles for Acid-Responsive Drug Delivery
Santosh Aryal, Che-Ming Jack Hu and Liangfang ZhangACS Nano2010 4 (1), 251-258Polymer−Cisplatin Conjugate Nanoparticles for Acid-Responsive Drug Delivery
Santosh Aryal, Che-Ming Jack Hu and Liangfang ZhangACS Nano2010 4 (1), 251-258We report the synthesis of novel acid-responsive therapeutic nanoparticles (NPs) with sub-100 nm size consisting of polymer−cisplatin conjugates. The uniqueness of these drug delivery polymeric NPs lies in the covalent conjugation of each cisplatin drug ...
2-(4-(tetrahydro-2H-pyran-2-yloxy)-undecyl)-propane-1,3-diamminedichloroplatinum(II): A Novel Platinum Compound that Overcomes Cisplatin Resistance and Induces Apoptosis by Mechanisms Different from that of Cisplatin
Andrea Dietrich, Thomas Mueller, Reinhard Paschke, Bernd Kalinowski, Timo Behlendorf, Franziska Reipsch, Angelika Fruehauf, Hans-Joachim Schmoll, Charlotte Kloft and Wieland VoigtJournal of Medicinal Chemistry2008 51 (17), 5413-54222-(4-(tetrahydro-2H-pyran-2-yloxy)-undecyl)-propane-1,3-diamminedichloroplatinum(II): A Novel Platinum Compound that Overcomes Cisplatin Resistance and Induces Apoptosis by Mechanisms Different from that of Cisplatin
Andrea Dietrich, Thomas Mueller, Reinhard Paschke, Bernd Kalinowski, Timo Behlendorf, Franziska Reipsch, Angelika Fruehauf, Hans-Joachim Schmoll, Charlotte Kloft and Wieland VoigtJournal of Medicinal Chemistry2008 51 (17), 5413-5422(4-(tetrahydro-2H-pyran-2-yloxy)R1)R2-diamminedichloroplatinum(II) complexes (1−12) consisting of CDDP linked to THP via aliphatic CH2-spacers were tested in two TGCT cell lines. The most promising compound, 2-(4-(tetrahydro-2H-pyran-2-yloxy)-undecyl)-...
DNA Binding and Topoisomerase II Inhibitory Activity of Water-Soluble Ruthenium(II) and Rhodium(III) Complexes
Sanjay Kumar Singh, Shweta Joshi, Alok Ranjan Singh, Jitendra Kumar Saxena, and Daya Shankar PandeyInorganic Chemistry2007 46 (25), 10869-10876DNA Binding and Topoisomerase II Inhibitory Activity of Water-Soluble Ruthenium(II) and Rhodium(III) Complexes
Sanjay Kumar Singh, Shweta Joshi, Alok Ranjan Singh, Jitendra Kumar Saxena, and Daya Shankar PandeyInorganic Chemistry2007 46 (25), 10869-10876Water-soluble piano-stool arene ruthenium complexes based on 1-(4-cyanophenyl)imidazole (CPI) and 4-cyanopyridine (CNPy) with the formulas [(η6-arene)RuCl2(L)] (L = CPI, η6-arene = benzene (1), p-cymene (2), hexamethylbenzene (3); L = CNPy, η6-arene = ...
Tools
-
Add to Favorites
-
Download Citation
-
Email a Colleague -
Permalink
Order Reprints
Rights & Permissions
Citation Alerts
History
- Published In Issue December 15, 2005
- Received July 7, 2005
ACS
Network
Facebook
Tweet This
CiteULike
Newsvine
Digg This
Delicious
